New 52 Week Low Today

Reneo Pharmaceuticals Inc RPHM:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 2:18 PM EST
1.84quote price arrow down-0.07 (-3.66%)
Volume
24,928
52 week range
1.79 - 10.00
Loading...
  • Open1.95
  • Day High1.97
  • Day Low1.79
  • Prev Close1.91
  • 52 Week High10.00
  • 52 Week High Date12/27/21
  • 52 Week Low1.79
  • 52 Week Low Date12/08/22

Key Stats

  • Market Cap45.135M
  • Shares Out24.53M
  • 10 Day Average Volume0.01M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-78.48

KEY STATS

  • Open1.95
  • Day High1.97
  • Day Low1.79
  • Prev Close1.91
  • 52 Week High10.00
  • 52 Week High Date12/27/21
  • 52 Week Low1.79
  • 52 Week Low Date12/08/22
  • Market Cap45.135M
  • Shares Out24.53M
  • 10 Day Average Volume0.01M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-78.48

RATIOS/PROFITABILITY

  • EPS (TTM)-2.00
  • P/E (TTM)-0.92
  • Fwd P/E (NTM)-0.81
  • EBITDA (TTM)-49.83M
  • ROE (TTM)-36.50%
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date03/21/2023(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Reneo Pharmaceuticals Inc

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Reneo Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company. The Company is focused on the developing therapies for patients with rare genetic mitochondrial diseases. The Company is engaged in developing REN001 to modulate genes critical to metabolism and generation of ATP, which is the source of energy for cellular processes. REN001 is a selective peroxisome proliferator-activated receptor delta (PPARd) agonist that has been shown to transcription of genes...
Michael Grey
Executive Chairman of the Board
Gregory Flesher
President, Chief Executive Officer, Director
Michael Cruse
Chief Operating Officer
Jennifer Lam CPA
Principal Financial and Accounting Officer, Vice President - Finance and Administration
Address
18575 Jamboree Road, Suite 275-S
Irvine, CA
92612
United States

Top Peers

SYMBOLLASTCHG%CHG
MBIO
Mustang Bio Inc
0.4044+0.008+2.0182%
IMNM
Immunome Inc
4.11-0.12-2.84%
CKPT
Checkpoint Therapeutics Inc
3.80-0.34-8.21%
TCRR
TCR2 Therapeutics Inc
1.22-0.05-3.94%
RVPH
Reviva Pharmaceuticals Holdings, Inc.
3.93-0.10-2.48%